0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Gary N. Fox, MD
JAMA. 2014;311(13):1350-1351. doi:10.1001/jama.2013.286235.

Special Communication | 
Richard A. Cooper, MD; Prakash Laud, PhD; Craig L. Dietrich, BS
JAMA. 1998;280(9):788-794. doi:10.1001/jama.280.9.788.

Special Communication | 
Richard A. Cooper, MD; Tim Henderson, MSPH; Craig L. Dietrich, BS
JAMA. 1998;280(9):795-802. doi:10.1001/jama.280.9.795.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Brief Report  | 
Hair and Nail Changes During Long-term Therapy With Ibrutinib for Chronic Lymphocytic Leukemia
Carole Bitar, MD; Mohammed Z. H. Farooqui, MD; Janet Valdez, PA; et al.
JAMA Dermatology
Case Report/Case Series  | 
Heterozygosity for a Novel Missense Mutation in the ITGB4 Gene Associated With Autosomal Dominant Epidermolysis Bullosa
Iana Turcan, MD; Anna M. G. Pasmooij, PhD; Peter C. van den Akker, MD, PhD; et al.
JAMA Dermatology
Research Letter  | 
Histologic Evidence of Melanocytes Isolated to the Nail Matrix
Rashek Kazi, PhD; Sara Moghaddam, MD; Paul Chu, MD; et al.
JAMA Dermatology
Observation  | 
Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
Arjun Dhayalan, BS; Brett A. King, MD, PhD